KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,838,000 | -10.2% | 525,262 | 0.0% | 0.44% | -6.8% |
| Q2 2021 | $10,952,000 | -26.2% | 525,262 | 0.0% | 0.47% | -9.2% |
| Q1 2021 | $14,849,000 | -13.4% | 525,262 | 0.0% | 0.52% | -31.9% |
| Q4 2020 | $17,155,000 | -46.7% | 525,262 | -50.0% | 0.77% | -58.8% |
| Q3 2020 | $32,172,000 | +88.0% | 1,050,000 | 0.0% | 1.86% | +51.5% |
| Q2 2020 | $17,115,000 | – | 1,050,000 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |